3D ECG for Detection of Cardiomyopathy
3D ECG for Detection of Cardiomyopathy in Heart Failure
| 赞助商 |
首席赞助商: University Hospital, Essen |
|---|---|
| 资源 | University Hospital, Essen |
| 简要总结 | There is existing data in the literature that suggests an additional predictive value of three dimensional ECG with respect to the presence of electrical abnormalities and for an existing cardiac disease. Especially regarding patients who suffered from a myocardial infarction in the past (post MI patients), evidence has been provided for a potential association of 3D repolarisation abnormalities and incidence of sudden cardiac death (SCD). In addition, there is some vague evidence of so called 3D ECG and prediction of coronary artery disease. This 3D ECG device is using the technology of 3D ECG vector loops and is assessing the variability of these ECG vector loops in the 3-dimensional space. Based on these data, the parameters of 3D ECG are suggested to carry certain value to predict or to identify individuals already suffering from a cardiac disease or being at risk experiencing a cardiac event in the future. In this context we performed a preliminary study with 3D-ECG device in healthy volunteers evaluating the robustness of this method with respect to reproducibility, intra- and intra-observer variability which could be confirmed. We thus postulate that the 3D ECG technology might bear the potential to serve as a sufficient screening method for diagnosing cardiomyopathy in patients with an unknown heart failure etiology. |
| 总体状况 | Recruiting | ||||
|---|---|---|---|---|---|
| 开始日期 | 2021-03-14 | ||||
| 完成日期 | 2021-10-14 | ||||
| 主要完成日期 | 2021-09-14 | ||||
| 研究类型 | Observational | ||||
| 主要结果 |
|
||||
| 注册 | 175 |
| 健康）状况 | |
|---|---|
| 介入 |
干预类型: Diagnostic Test 干预名称: 3D-ECG 描述: Patient recieves 3D-ECG Assessement 手臂组标签: Patient recieving 3D-ECG-Evaluation |
| 合格 |
取样方式: Probability Sample
标准:
Inclusion Criteria: - Age >18 Years - Established diagnosis heart failure and suggested cardiomyopathy Exclusion Criteria: - Patients unable to sign informed consent - Pacemaker-stimulated ECG 性别: All 最低年龄: 18 Years 最高年龄: N/A 健康志愿者: No |
| 总体官员 |
|
||||||
|---|---|---|---|---|---|---|---|
| 总体联系方式 |
姓: Reza Wakili, Prof. 电话: 00492017234802 电子邮件: reza.wakili@uk-essen.de |
||||||
| 位置 |
|
| 位置国家 |
Germany |
|---|---|
| 验证日期 |
2021-04-01 |
| 责任方 |
类型: Sponsor |
| 扩大了访问范围 | No |
| 条件浏览 | |
| 臂组 |
标签: Patient recieving 3D-ECG-Evaluation |
| 患者资料 | No |
| 研究设计信息 |
观察模型: Cohort 时间透视: Prospective |
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Heart Failure的临床试验
-
NCT05806970尚未招聘条件：Heart Failure With Reduced Ejection Fraction
-
NCT05806606尚未招聘条件：Heart Failure, Self Care, Empowerment, Transitional Care, Disease Management
-
NCT05802563邀请参加条件：Atrial Fibrillation, Heart Failure, Systolic
-
NCT05792059招聘中条件：Heart Failure With Preserved Ejection Fraction (HFpEF)
-
NCT05797649尚未招聘条件：Pleural Effusion, Heart Failure, Malignant Neoplasm, Fluid Overload, Hypoalbuminemia, Renal Failure, Cirrhosis, Infections
-
NCT05799638尚未招聘条件：Heart Failure With Reduced Ejection Fraction
-
NCT05778084招聘中条件：Heart Failure With Reduced Ejection Fraction
-
NCT05791227尚未招聘